Catalyst Wire Dossier Catalyst Wire Dossier

QHRD106 Injection

QHRD106 · Changzhou Qianhong Bio-pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QHRD106 Injection, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. [Phase 2]

See pricing